PDCD1LG2 and cutaneous melanoma: A transcriptomic analysis performed by Danilova and colleagues used The Cancer Genome Atlas datasets and found that PD-L2 mRNA expression indicated good prognosis in skin cutaneous melanoma (SKCM) but had no prognostic role in other 8 tumors (35).